RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Brazil: Regulatory Agency Gets Authority to Deny Patents

Brazil: Regulatory Agency Gets Authority to Deny Patents

Posted 04 June 2012 | By Ansis Helmanis

As the result of a new patent review process, Brazilian regulatory authority Anvisa is being given the authority to deny the grant of a patent for a medical product.

The agency can make deny a decision to grant a patent if it determines the patent would impede universal access to medicines-a Brazilian constitutional right. This so-called right of "prior consent" by Anvisa would be binding on Brazil's Patent and Trademark Office (INPI).

Read more:

Patent Review Process Overview

More Breaking News from RegLink


© 2022 Regulatory Affairs Professionals Society.

Tags: Patent, brazil